📺 Live now at #EHFG2026
✅ Health sovereignty, global solidarity & the WHO: ehfg.live/stage/kursaa...
@gasteinforum.bsky.social
@gasteinforum.bsky.social📺 Live now at #EHFG2026
✅ Health sovereignty, global solidarity & the WHO: ehfg.live/stage/kursaa...
@gasteinforum.bsky.social📺 Live now at #EHFG2026
✅ Regulatory sandboxes as innovation partnerships: ehfg.live/stage/confer...
✅ The implementation gap: ehfg.live/stage/kursaa...
@gasteinforum.bsky.social📺 Live now at #EHFG2026
✅ Shaping resilient generations: ehfg.live/stage/confer...
@gasteinforum.bsky.social
@gasteinforum.bsky.social📺 Live now at #EHFG2026
✅ Transforming for health and security: ehfg.live/stage/kursaa...
✅ The regulatory shield: ehfg.live/stage/confer...
@gasteinforum.bsky.social📺 Live now at #EHFG2026
✅ Europe's health security as strategic defence: ehfg.live/stage/kursaa...
@gasteinforum.bsky.social📺 Live now at #EHFG2026
✅ Immunisation as a strategic investment: ehfg.live/stage/kursaa...
✅ Maintaining momentum in Europe’s Beating Cancer Plan: ehfg.live/stage/confer...
@gasteinforum.bsky.social📺 Live now at #EHFG2026
✅ The invisible burden of mental health on non-communicable diseases: ehfg.live/stage/kursaa...
✅ New threats, new responses: ehfg.live/stage/confer...
@gasteinforum.bsky.social📺 Live now at #EHFG2026
✅ Digital mental health in Europe: ehfg.live/stage/kursaa...
✅ Translating EU pharma reform into patient access: ehfg.live/stage/confer...
@gasteinforum.bsky.socialThe revised EU Pharmaceutical Legislation is entering the implementation phase.
The key question now is: how can it deliver faster and more equitable patient access across Europe?
Join PHARMIG this morning at 09:00 to discuss: bit.ly/4wMj6Mm
@gasteinforum.bsky.social📺 Live now at #EHFG2026
✅ With a little help from my (neighbouring) friends: ehfg.live/stage/confer...
@gasteinforum.bsky.socialMore equitable access through EU patient mobility.
From 18:15 at #EHFG2026, the University of Verona and FLASH project ask how patient mobility and cross-border cooperation can help make that a reality.
@gasteinforum.bsky.social📺 Live now at #EHFG2026
✅ Advancing national policy solutions for equitable rare disease access and care: ehfg.live/stage/kursaa...
✅ Convergence science testbeds and digital twins: ehfg.live/stage/confer...
@gasteinforum.bsky.social30 million Europeans. One shared challenge.
Today at #EHFG2026, Alexion AstraZeneca Rare Disease, Biogen, & PTC Therapeutics will explore how national policies can improve diagnosis, treatment & care for people living with rare diseases.
Follow online ➡️ bit.ly/4wMj6Mm
@gasteinforum.bsky.social📺 Live now at #EHFG2026
✅ A competitive Europe starts with health!: ehfg.live/stage/kursaa...
@gasteinforum.bsky.social⌛️ Starting in 30 minutes: the 1st #EHFG2026 plenary, “A competitive Europe starts with health!”
Can Europe be competitive without a healthy population? Join the discussion on why health is critical to Europe’s economic future.
Register to watch ➡️ bit.ly/4wMj6Mm
@gasteinforum.bsky.social📺 Live now at #EHFG2026
✅ Patients for innovation: ehfg.live/stage/kursaa...
✅ Securing Europe’s access to future medical breakthroughs: ehfg.live/stage/confer...
@gasteinforum.bsky.socialEurope faces a stark choice: remain a late adopter of innovation developed elsewhere, or take back its place as a primary region for health R&D and access to innovation for patients. Join EFPIA at #EHFG2026 today from 12:15–13:30 to learn more ➡️ bit.ly/4wMj6Mm
@gasteinforum.bsky.socialWhat changes when medicines are developed “with patients” rather than simply “for patients”? At #EHFG2026 today, from 12:15–13:30, the European Medicines Agency will explore the evolving contribution of patients across the medicines development continuum ➡️ bit.ly/4wMj6Mm
@gasteinforum.bsky.social📺 Live now at #EHFG2026
✅ Unlocking European competitiveness: ehfg.live/stage/kursaa...
✅ Private equity in healthcare: ehfg.live/stage/confer...